Sun Pharma says it will not sell semaglutide drugs in India until Novo Nordisk patent expires
Novo Nordisk and Sun Pharma clashed in the Delhi High Court over semaglutide, with Sun Pharma agreeing not to sell in India until the patent expires in March 2026 but continuing exports.